Merck’s (NYSE:MRK) Gardasil is the leader in the human papillomavirus (HPV) vaccines market. HPV is a group of more than 200 related viruses, of which several are spread through direct sexual ...

Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...

The long-awaited endorsement of GlaxoSmithKline's HPV vaccine Cervarix is widely expected to pave a short path to formal FDA approval. But Merck isn't sounding all that concerned that its vaccine, ...

China’s vaccine landscape is shifting after local biotech Xiamen Innovax Biotech unveiled the country’s first domestically ...

Because Gardasil is a vaccine, Merck doesn’t have to worry about losing its patent. The only competition is from GlaxoSmithKline’s Cervarix, which has little market share and covers fewer strains of ...

Merck's stock tumbled 11.8% Tuesday, putting it on track for its biggest one-day selloff in almost 17 years, after the drug company's softer-than-expected guidance amid struggles for its HPV ...

Merck cited competition that undercut Januvia/Janumet, while lower demand in China hammered away at sales of Gardasil. Merck lowered its sales view for the year by $5 million at the midpoint.

Merck believes it can win near-term approval for a new HPV vaccine that will do better than Gardasil in guarding women against the virus that causes cervical cancer. But the vaccine's estimated ...

Merck’s full-year 2025 revenue guidance fell short of what some analysts were expecting, at a range of $64.1 billion to $65.6 billion.

But Merck's vaccine that prevents cancer from HPV, ... Merck said the decline was primarily due to lower prices of the drug in the U.S., along with generic competition in several countries. ...

But Merck's vaccine that prevents cancer from HPV, the most common sexually transmitted infection in the U.S., posted another quarter of lighter-than-expected sales. Revenue from the shot ...

Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations. The company said that sales range reflects a decision to halt shipments of Gardasil, a ...